BioAdaptives gets IRB approval for human trial of weight management product Zeranovia

BIOADAPTIVES, INC.

IRB approved human clinical trial for Zeranovia, a weight management supplement.
First phase to confirm dosing and identify side effects; participant slots quickly filled.
CEO notes less than 1% of nutraceuticals undergo human trials; aims for scientific proof.
Trial managed by doctors in Las Vegas, NV; next stage open to more participants.
If successful, Zeranovia could compare favorably to synthetic GLP-1 and GIP treatments.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.